• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Breath Biopsy Aims to Detect Lung Infections Early

Breath Biopsy Aims to Detect Lung Infections Early

by The Scientist Staff | Jul 28, 2025 | Clinical Diagnostics Insider, Emerging Tests-dtet

A novel breath test that could transform Pseudomonas aeruginosa detection in cystic fibrosis patients

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Rethinking Lyme Disease Testing: A New Approach to Early Detection

Rethinking Lyme Disease Testing: A New Approach to Early Detection

by Jason Barker, ND | Jun 4, 2025 | Clinical Diagnostics Insider, Emerging Tests-dtet

New research marks a promising step toward rethinking how we identify and manage Lyme disease and related infections in the clinical lab

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
FDA Watch: DOGE Changes at FDA Upend Approval Processes, Observers Say

FDA Watch: DOGE Changes at FDA Upend Approval Processes, Observers Say

by Ron Shinkman | Mar 28, 2025 | Essential, FDA-lca, Lab Industry Advisor

Pre-submission and Q-Submission meetings apparently have been halted, for now

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
When Is Genome Sequencing Advisable?

When Is Genome Sequencing Advisable?

by Michael Schubert, PhD | Nov 25, 2024 | Clinical Diagnostics Insider, Emerging Tests-dtet, Testing Trends-dtet

With patient and provider demand for WGS on the rise, what should laboratorians know about ordering and interpreting this testing?

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Removing Restrictions to Germline Testing

Removing Restrictions to Germline Testing

by Oscelle Boye, MBiomed | Sep 23, 2024 | Clinical Diagnostics Insider, Emerging Tests-dtet

With the global cancer burden growing, is a universal germline genomic testing approach the key to more effectively combating the disease?

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com